# Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery

> **NCT00438464** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 204 (actual)

## Conditions studied

- Adenocarcinoma of the Prostate
- Stage II Prostate Cancer

## Interventions

- **DRUG:** Finasteride
- **OTHER:** Placebo
- **PROCEDURE:** Prostatectomy
- **OTHER:** Laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00438464
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 204 (ACTUAL)
- **Last updated:** 2016-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00438464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00438464, "Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00438464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*